FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Ranitidine Hydrochloride 150mg and 300mg Capsules (Manufactured by Novitium Pharma LLC) Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA)
Select Varieties of Breakstone’s Cottage Cheese are Voluntarily Being Recalled Due to Potential Presence of Foreign Material
Food & Beverages
Patient Engagement, Awareness and Medical Device Cybersecurity
To help better communicate medical device cybersecurity risks to patients, the FDA goes straight to the source.
Patient Perspective Is Vital to FDA's Work
FDA considers patients the real experts when it comes to their health conditions, as illustrated in the recent rare disease disorder summit.
To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality
Drug manufacturers with very high reliability usually have a mature quality management system — purchasers should have the ability to readily identify them.
Animal & Veterinary
Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention Guidance for Industry